Interestingly, this was consistent with a previous study of non-small cell lung cancer (NSCLC)43, which indicated an increased likelihood of RASSF1A methylation in heterogeneous controls compared to autologous controls. The gene discussed is RASSF1; the disease is non-small cell lung carcinoma.